| Primary |
| Product Used For Unknown Indication |
18.2% |
| Drug Use For Unknown Indication |
13.6% |
| Hypertension |
13.6% |
| Asthma |
9.1% |
| Atrial Fibrillation |
9.1% |
| Anxiety |
4.5% |
| Chronic Obstructive Pulmonary Disease |
4.5% |
| Oedema |
4.5% |
| Osteoporosis |
4.5% |
| Peripheral Oedema |
4.5% |
| Pulmonary Hypertension |
4.5% |
| Right Ventricular Failure |
4.5% |
| Urinary Tract Infection |
4.5% |
|
| Renal Failure Acute |
23.1% |
| Gastrointestinal Tract Mucosal Pigmentation |
7.7% |
| Hepatitis |
7.7% |
| Medication Error |
7.7% |
| Post Procedural Complication |
7.7% |
| Presyncope |
7.7% |
| Spinal Epidural Haematoma |
7.7% |
| Tinnitus |
7.7% |
| Tricuspid Valve Incompetence |
7.7% |
| Ventricular Dysfunction |
7.7% |
| Ventricular Tachycardia |
7.7% |
|
| Secondary |
| Product Used For Unknown Indication |
65.9% |
| Hypertension |
7.2% |
| Drug Use For Unknown Indication |
4.4% |
| Hypertension Arterial |
3.4% |
| Type 2 Diabetes Mellitus |
2.8% |
| Cardiac Failure |
1.9% |
| Hypertension Arterial |
1.6% |
| Depression |
1.6% |
| Urinary Tract Infection |
1.6% |
| Abnormal Behaviour |
1.3% |
| Cardiac Disorder |
1.3% |
| Dyslipidaemia |
1.3% |
| Pain |
1.3% |
| Hypertension |
0.9% |
| Arrhythmia |
0.6% |
| Ascites |
0.6% |
| Blood Pressure |
0.6% |
| Chronic Ischemic Heart Disease, Unspecified |
0.6% |
| Oedema |
0.6% |
| Osteomyelitis |
0.6% |
|
| Renal Failure Acute |
18.2% |
| Toxicity To Various Agents |
12.7% |
| Syncope |
9.1% |
| Presyncope |
7.3% |
| Rhabdomyolysis |
5.5% |
| Thrombocytopenia |
5.5% |
| Vomiting |
5.5% |
| Angioedema |
3.6% |
| Dehydration |
3.6% |
| Overdose |
3.6% |
| Premature Delivery |
3.6% |
| Stevens-johnson Syndrome |
3.6% |
| Toxic Epidermal Necrolysis |
3.6% |
| Weight Loss Poor |
3.6% |
| Cheilitis |
1.8% |
| Disturbance In Attention |
1.8% |
| Dysstasia |
1.8% |
| Hypokalaemia |
1.8% |
| Hypomagnesaemia |
1.8% |
| Inappropriate Antidiuretic Hormone Secretion |
1.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
24.1% |
| Plasma Cell Myeloma |
14.7% |
| Type 2 Diabetes Mellitus |
9.5% |
| Hypertension |
6.9% |
| Osteoporosis |
5.2% |
| Drug Use For Unknown Indication |
3.5% |
| Atrial Fibrillation |
3.3% |
| Chronic Myeloid Leukaemia |
3.3% |
| Multiple Myeloma |
3.1% |
| Myelodysplastic Syndrome |
3.1% |
| Prophylaxis |
3.1% |
| Depression |
2.8% |
| Immunodeficiency Common Variable |
2.8% |
| Prostate Cancer Metastatic |
2.6% |
| Parkinson's Disease |
2.4% |
| Nuclear Magnetic Resonance Imaging |
2.1% |
| Chronic Lymphocytic Leukaemia |
1.9% |
| Colorectal Cancer Metastatic |
1.9% |
| Diabetes Mellitus |
1.9% |
| Pulmonary Arterial Hypertension |
1.9% |
|
| Vomiting |
11.5% |
| Renal Failure Acute |
9.7% |
| Pneumonia |
7.9% |
| Thrombocytopenia |
6.1% |
| Weight Decreased |
6.1% |
| Oedema Peripheral |
4.8% |
| Renal Failure Chronic |
4.8% |
| Tremor |
4.8% |
| Rash |
4.2% |
| Sepsis |
4.2% |
| Toxicity To Various Agents |
4.2% |
| White Blood Cell Count Decreased |
4.2% |
| Platelet Count Decreased |
3.6% |
| Tachycardia |
3.6% |
| Treatment Failure |
3.6% |
| Urticaria |
3.6% |
| Weight Increased |
3.6% |
| Death |
3.0% |
| International Normalised Ratio Increased |
3.0% |
| Pancreatitis |
3.0% |
|
